Adapting Behavioral Interventions for Dementia to Address NCDs and Mental Health
Interventions: Behavioral: BECOME-D Intervention
Sponsors: Possible; University of California, San Francisco; National Institute of Mental Health (NIMH); Ministry of Health and Population, Nepal
Completed
MDMA Assisted Therapy for BN
Interventions: Drug: MDMA-AT; Drug: MDMA-AT-BN; Behavioral: Standard Treatment (ST)
Sponsors: Icahn School of Medicine at Mount Sinai
Not yet recruiting
Pilot Randomized Trial of BA-GSH in VA PC-MHI
Interventions: Behavioral: Behavioral Activation-Guided Self-Help
Sponsors: VA Office of Research and Development
Not yet recruiting
Efficacy and Safety of Sertraline Combined With Lactobacillus Crispatus in Adolescents With Depression : A Multicenter Randomized Controlled Trial
Interventions: Combination Product: Sertraline combined with Lactobacillus crispatus; Combination Product: Sertraline combined with placebo
Sponsors: First Affiliated Hospital of Chongqing Medical University
Not yet recruiting
Transcranial Photobiomodulation (tPBM) for Somatic Symptoms in Treatment-Resistant Depression
Interventions: Device: transcranial photobiomodulation
Sponsors: Taipei Veterans General Hospital, Taiwan
Recruiting
Photobiomodulation on Core Symptoms of Autism
Interventions: Device: Photobiomodulation
Sponsors: Suez University
Not yet recruiting
Internet addiction among nursing students: application of latent profile analysis and network analysis
Shinya Yamanaka
Dr. Shinya Yamanaka is recognized for the generation of induced pluripotent stem cells (iPSCs) from fibroblasts by a combination of multiple transcription factors, and he won the Nobel Prize in Physiology or Medicine in 2012 jointly with Sir John B. Gurdon for this discovery. Twenty years after the discovery, the Cell Reports Medicine editorial team discusses with Dr. Yamanaka the scientific, technical, and translational milestones that have shaped the field of regenerative medicine. We also discuss the role of iPSCs in disease modeling and drug discovery, the interplay with genome editing, and ongoing issues that still prevent the widespread clinical application of iPSC-derived therapies.
The healthy human global project – Hong Kong: A community-based cross-sectional study of a healthy Asian population
A deeply phenotyped healthy Hong Kong cohort reveals age- and sex-dependent immune, clinical, and lifestyle variation, highlighting population-specific differences and the need to extend systems immunology frameworks beyond European ancestry.

